Revelation Biosciences, Inc. · NASDAQ:REVB

Rolke James had 10,115 Revelation Biosciences, Inc. shares withheld for tax (Form 4)

Traded Apr 30, 2026 · Filed May 1, 2026

On Apr 30, 2026, Rolke James (Director, Chief Executive Officer) had 10,115 Revelation Biosciences, Inc. shares withheld for tax at US$1.13 for US$11,430, leaving 214,738 shares. Filed May 1, 2026 (Form 4).

Withheld for tax
10,115 shares
Price
US$1.13
Value
US$11,430
Holding after
214,738 shares
Trading plan
No
Role
Director, Chief Executive Officer

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Apr 30, 2026Common StockShares withheld for tax10,115US$1.13214,738Direct

Source

View original at SEC

Related